Shadow Lab Exposed: Bareskrim Polri Dismantles Five-Year Counterfeit Children’s Vitamin Operation in Lampung

JAKARTA – In a significant strike against the illicit trade of pharmaceutical products, the Directorate of Special Economic Crimes (Dittipideksus) of the Indonesian National Police (Bareskrim Polri) has successfully dismantled an underground manufacturing facility in Lampung responsible for producing counterfeit versions of the popular children’s multivitamin, "Apialys."

The operation, which had been running clandestinely since 2021, preyed on unsuspecting parents across the archipelago, flooding the digital marketplace with substandard products. The Bareskrim Polri has officially named an individual identified by the initials IKS as the primary suspect in the case, marking a critical victory for consumer protection and intellectual property rights in Indonesia.

The Anatomy of the Fraud: Main Facts

The discovery of the illicit facility follows a rigorous investigation into the unauthorized production and distribution of health supplements. According to the Director of Special Economic Crimes at Bareskrim Polri, Brigadier General Ade Safri Simanjuntak, the suspect IKS operated an unlicensed factory that mimicked the packaging and branding of the legitimate Apialys product—a widely trusted brand manufactured by PT Lapi Laboratories.

The counterfeiters did not merely replicate the box; they produced a fraudulent syrup concoction using forest honey as a base, which was then marketed under the guise of the established medical brand. The products were sold extensively through major e-commerce platforms and social media channels, successfully bypassing traditional pharmaceutical oversight.

The suspect allegedly priced these illicit goods at approximately IDR 50,000 per bottle, a price point strategically chosen to attract budget-conscious parents seeking to bolster their children’s health. By leveraging the reach of digital marketing, IKS was able to penetrate households across various regions in Indonesia, effectively creating a nationwide network of counterfeit distribution.

Chronology: Five Years of Deception

The investigation into IKS’s activities was prompted by a formal complaint filed by PT Lapi Laboratories, the rightful owner of the Apialys trademark. The company had detected an alarming influx of suspicious, unauthorized versions of their product circulating online.

1. The Origins (2021): Investigators determined that the suspect established the illegal "factory" in Lampung in 2021. For nearly five years, IKS managed to evade detection by operating within a domestic framework, utilizing residential or semi-industrial settings to hide the production line.
2. The Digital Expansion: Recognizing the limitations of physical retail, the suspect pivoted to e-commerce and social media. By utilizing targeted ads and social media engagement, the perpetrator built a facade of legitimacy, frequently communicating with parents who believed they were purchasing authentic medical supplements for their children.
3. The Investigation (2026): Upon receiving the report from the trademark holder, Bareskrim Polri initiated a deep-dive investigation. Through digital forensics and surveillance, investigators traced the supply chain back to the source in Lampung.
4. The Raid and Arrest: The decisive operation resulted in the arrest of IKS and the seizure of the manufacturing site. The facility contained not only the final product but also the infrastructure required for mass production, including professional-grade labeling equipment and raw materials.
5. Legal Status (October 2026): Following the collection of evidence, the case file was submitted to the Prosecutor’s Office. As of October 9, 2026, the Public Prosecutor (JPU) at the Bandar Lampung District Attorney’s Office has declared the file "P-21," confirming that the investigation is complete and the case is ready for trial.

Supporting Data and Forensic Evidence

The raid conducted by Dittipideksus Bareskrim Polri was highly fruitful, providing a wealth of physical evidence that leaves little room for defense. During the search, authorities confiscated:

• Finished Goods: Numerous bottles of syrup labeled "Apialys."
• Production Materials: Large quantities of counterfeit labels, stickers, and packaging materials specifically designed to mimic the original branding.
• Technical Infrastructure: Computers, monitors, printers, and flash drives containing digital templates and formatting for the counterfeit labels.
• Manufacturing Equipment: Machinery used for filling, sealing, and capping bottles, indicating a sophisticated level of illegal industrial activity.
• Financial Records: Detailed logs, ledgers, and transaction books that catalog five years of illicit sales, providing a roadmap for investigators to track the extent of the fraud and the flow of illicit profits.

Brigadier General Ade Safri Simanjuntak emphasized that the sheer volume of evidence suggests a highly organized and calculated operation. The ability of the suspect to sustain this for five years highlights significant gaps in the monitoring of e-commerce platforms regarding health-related goods.

Official Responses: A Call for Vigilance

In his official statement, Brigadier General Ade Safri Simanjuntak expressed deep concern regarding the nature of the crime. "Products intended for children require special attention, both in terms of the authenticity of the product, compliance with legal provisions, and the protection of consumer rights," he stated.

He further elaborated that the crime goes beyond a simple intellectual property dispute. "The use of trademarks without rights or the use of trademarks that violate legal provisions not only harms the legitimate trademark owner but also misleads the public in making product choices. Parents, who trust these brands for their children’s health, have been the primary victims of this deception."

The Ministry of Health and the Indonesian Food and Drug Authority (BPOM) have historically cautioned against purchasing health products from unverified online sellers. This case serves as a stark reminder of the dangers inherent in the unregulated online drug trade, where the lack of GMP (Good Manufacturing Practice) standards can lead to products that are not only ineffective but potentially dangerous due to contamination or improper formulation.

Implications: The Legal and Social Aftermath

The case against IKS is being pursued under Article 100, Paragraph (2) of Law Number 20 of 2016 concerning Trademarks and Geographical Indications. This law carries significant penalties, including imprisonment and hefty fines, intended to deter the rampant growth of counterfeit goods in the Indonesian market.

1. Legal Ramifications

With the file declared P-21, the suspect now faces the judicial system. The prosecution will likely focus on the duration of the crime and the scale of the distribution, which could lead to severe sentencing. The case is expected to set a precedent for how Indonesian authorities handle intellectual property theft involving sensitive pharmaceutical products.

2. E-commerce Responsibility

This incident has reignited the debate regarding the accountability of e-commerce platforms. As digital marketplaces continue to grow in Indonesia, the incident highlights the need for more stringent "Know Your Seller" (KYS) protocols. Platforms may face increased pressure from regulators to implement real-time verification for merchants selling food, drugs, and health supplements.

3. Impact on Consumer Trust

The psychological and health implications for the parents who unwittingly purchased these supplements are significant. While there have been no immediate reports of mass medical crises linked to this specific batch of counterfeits, the uncertainty remains a source of anxiety for the affected families. This case underscores the necessity for public education campaigns regarding how to distinguish between authorized pharmaceutical distributors and illegal sellers.

4. Protecting Intellectual Property

For PT Lapi Laboratories, the successful intervention by the police is a major relief. The case reinforces the importance of active brand monitoring and collaboration between private entities and law enforcement. Intellectual property rights are not just about protecting revenue; in the pharmaceutical industry, they are fundamentally linked to patient safety and the integrity of the supply chain.

As the legal proceedings against IKS move forward, the Indonesian authorities have signaled that they will continue to intensify efforts to monitor and purge the digital space of counterfeit medical products. The message to the public is clear: verify the source, check the authenticity of the product, and when in doubt, consult with licensed pharmacists. The fight against "shadow labs" like the one in Lampung is a crucial step toward ensuring that children’s health remains protected from the reach of opportunistic criminals.